Tirzepatide (Mounjaro, Zepbound) is a related but distinct medication that acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor co-agonist
Courcoulas, A.P., Christian, N.J., Belle, S.H., et al
As one gastroenterologist who took the survey said, it works for all issues exacerbated by obesity. While GLP-1RA medications may come with many benefits, they arent a silver bullet
The benefits of improved glycaemic control or weight management typically outweigh concerns about temporary hair thinning, particularly as telogen effluvium usually resolves spontaneously within 612 months
Because peptide drugs are difficult to absorb orally at reliable doses
Even women who are trying to eat well may fall short on B vitamins, vitamin D, zinc, magnesium, and other micronutrients when portions shrink and food intake becomes inconsistent